Cortexyme () Cash US GAAP (year values) |
|||||||||
2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
Cash, bln rub | 7.34 | 71.7 | 99.9 | 133.8 | 106.8 | 94.7 | |||
Changes by years, y/y, % | +877% | +39% | +34% | -20% | +95.3% |
Cortexyme. Cash, bln rub
Cortexyme. Cash, changes, %
Cortexyme () Cash US GAAP (quarter values) |
||||||||
2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
Cash, bln rub | 130.0 | 114.4 | 106.8 | 91.5 | 94.7 | 94.7 | ||
Changes by years, y/y, % | -10% | -17% | -20% | -38% | -27% | |||
Changes by quarters, q/q, % | -12% | -12% | -7% | -14% | +3% |